Popular Articles

New HIV Microbicide Developed-- And A Way To Mass Produce It In Plants
In what could be a major pharmaceutical breakthrough, research published online in The FASEB Journal describes how scientists from St George"s, University of London have devised a one-two punch to stop HIV. First the report describes a new protein that can kill the virus when used as a microbicide. Then the report shows how it might be possible to manufacture this protein in quantities large enough to make it affordable for people in developing countries.
drugs without prescription
Oncologic Drugs Advisory Committee Meeting Set By FDA
Medical Industry E-Mail News Service™ -- July 07 2009 -- The US Food & Drug Administration (FDA) has announced that its Oncologic Drugs Advisory Committee will meet on July 15 2009, in Gaithersburg MD, to discuss (1) new drug application (NDA) 022-447, proposed trade name Yondelis (trabectedin) powder, for concentrate for solution for intravenous infusion, Centocor Ortho Biotech Products, L.P., proposed indication in combination with Doxcil (doxorubicin HCl liposome injection), for treating patients with relapsed ovarian cancer; and (2) supplemental new drug application (sNDA) 050-718/S-039, Doxil (doxorubicin HCl liposome injection), for intravenous infusion, Centocor Ortho Biotech Products, L.P., proposed indication in combination with docetaxel for treating patients with locally advanced or metasatic breast cancer who have received prior anthracycline treatment. There is no charge to attend.
News of the day
Confirmed Link Between Chronic Infection And Immune-System Protein
The reason deadly infections like human immunodeficiency virus (HIV) and hepatitis C never go away is because these viruses disarm the body"s defense system. Researchers at the University of Alabama at Birmingham (UAB) have discovered that a key immunity protein must be present for this defense system to have a chance against chronic infection.
Health Insurance

'Provocative' New Evidence Links Vitamin D And Other Nutrients To Heart Disease

Emerging research suggests that nutritional factors including vitamin D, magnesium, and others may influence the risk and progression of cardiovascular disease. The new data on nutrition and heart disease were the topic of a recent symposium and are summarized in the July issue of The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation (SSCI). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and biomedical intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. "The prospect that macro- and micronutrients may play an important role in the appearance of diseases of the cardiovasculature and their progressive nature is both intriguing and provocative," according to the article"s preface by Dr. Karl T. Weber. The article highlights key findings presented at the SSCI"s Annual Scientific Session in New Orleans earlier this year. The symposium was presented in conjunction with the SSCI"s Cardiovascular Club and the International Academy of Cardiovascular Sciences/North America. New Evidence Links Vitamin D to Cardiovascular Disease Several recent studies have identified low vitamin D levels as a common problem with many adverse health effects, including increased rates of cardiovascular disease. People with vitamin D deficiency are at increased risk of high blood pressure, heart failure, and ischemic heart disease, according to Suzanne Judd, MPH, PhD, of University of Alabama at Birmingham and Dr. Vin Tangpricha of Emory University. In patients who already have heart disease, low vitamin D may increase the risk of high blood pressure or sudden death. Vitamin D deficiency may also help to explain the apparent relationship between osteoporosis-related fractures and heart failure, according to Dr. Syed H. Raza and colleagues. Osteoporosis and heart failure are both common conditions in older adults and share several risk factors including low vitamin D. Pending further research to clarify this relationship, patients with heart failure need attention to their risks of osteoporosis and fractures. So far, however, there is very little information on whether taking vitamin D supplements can avoid or reduce these risks. Rebecca B. Costello, PhD, of the National Institutes of Health"s Office of Dietary Supplements outlines federal research initiatives to understand the effects of vitamin D on health. She urges rigorous scientific studies to clarify the relationship between vitamin D and cardiovascular disease, as well as other chronic diseases. Other Nutrients May Also Affect Cardiovascular Risk Could folic acid help prevent heart disease? Folic acid (vitamin B9) reduces levels of the amino acid homocysteine, which affects cardiovascular risk, according to Dr. Lydia A. Bazzano of Tulane University. However, studies have found that taking folic acid to reduce homocysteine does not lower cardiovascular risk in adults. Taking folic acid during pregnancy does appear to reduce the risk of congenital heart defects, however. Low levels of nutrient magnesium may lead to a "cascade" of harmful inflammation-promoting events, according to Dr. Jay H. Kramer of George Washington University and colleagues. This may lead to disease of the heart muscle (cardiomyopathy), increasing vulnerability to injury from other forms of stress. Especially with the high rate of magnesium deficiency in the population, antioxidants and other medications in addition to magnesium supplements might help in reducing cardiovascular disease. Patients with heart failure especially African Americans are prone to an imbalance of several nutrients, according to a presentation by Dr. German Kamalov and colleagues. The imbalance is accompanied by activation of certain hormones, leading to inflammation and wasting of soft tissues and bone. The authors discuss approaches to recognizing this nutritional imbalance, and suggest that a "polynutrient supplement" including calcium, magnesium, zinc, selenium, and vitamins D, B12, and B1 might play a role in heart failure management. Despite the tantalizing new evidence, "The role of nutrition in the causation, prevention, and treatment of cardiovascular diseases is largely unexplored," Dr. Weber concludes. "Investigator-initiated, hypothesis-driven research conducted in a mode of discovery by a multidisciplinary team of basic and clinical scientists will undoubtedly open new frontiers and pave the way by identifying simple remedies that could advance the practice of medicine." About The American Journal of the Medical Sciences Founded in 1820, The American Journal of the Medical Sciences (AJMS) is the official journal of the Southern Society for Clinical Investigation. Regular features include Clinical and Basic Investigation studies, Reviews, Historical Articles, Case Reports, Images in the Medical Sciences. Other special features include contributions from the Southwestern Internal Medicine Conference, Cardiology Grand Rounds from the University of North Carolina and Emory University, Case Records of the VA Maryland Healthcare System/University of Maryland Medicine, and Clinical Pathological Correlation from Texas A&M Health Science/Scott & White Memorial Hospital, Images in the Medical Sciences. Lippincott Williams & Wilkins


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):